Beyaz is owned by Bayer Hlthcare.
Beyaz contains Drospirenone; Ethinyl Estradiol; Levomefolate Calcium.
Beyaz has a total of 3 drug patents out of which 2 drug patents have expired.
Expired drug patents of Beyaz are:
Beyaz was authorised for market use on 24 September, 2010.
Beyaz is available in tablet;oral dosage forms.
Beyaz can be used as prevention of pregnancy.
The generics of Beyaz are possible to be released after 08 February, 2030.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.|
|US6441168||BAYER HLTHCARE||Stable crystalline salts of 5-methyltetrahydrofolic acid|| |
(6 months ago)
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7163931||BAYER HLTHCARE||Compositions of estrogen-cyclodextrin complexes|| |
(11 months ago)
|US8617597||BAYER HLTHCARE||Pharmaceutical composition containing a tetrahydrofolic acid|| |
(7 years from now)
Market Authorisation Date: 24 September, 2010
Treatment: Prevention of pregnancy
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic